← Back to Clinical Trials
Recruiting NCT06800937

NCT06800937 Sphingolipidomic Profile in Anorexia Nervosa

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06800937
Status Recruiting
Phase
Sponsor Istituto Auxologico Italiano
Condition Anorexia Nervosa
Study Type OBSERVATIONAL
Enrollment 60 participants
Start Date 2024-06-19
Primary Completion 2026-06-30

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Determination of sphingolipidomic profile

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 60 participants in total. It began in 2024-06-19 with a primary completion date of 2026-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

: The objective of this research project will be to determine the sphingolipidomic profile in a group of women (\> 18 years) affected by Anorexia Nervosa (AN), phenotypically characterized (restricting \[AN-R\] vs binge-eating purging \[AN-BP\]). Specific questionnaires will be administered for the definition of the severity of the eating disorder and depressive state (suicidality), to which will be added the evaluation of gonadal function (i.e., plasma levels of estradiol/progesterone and use of oral contraceptives). Based on the specific lipidomic profile, which the present research project hopes to characterize, it will be possible to appropriately modify the diet of rehabilitation programs and, in the future, improve the effectiveness of the treatment itself, especially in the long term.

Eligibility Criteria

Patients with Anorexia Nervosa: Inclusion Criteria: * Female sex * Age: 18 years or older * Diagnosis of Anorexia Nervosa in the acute phase * Hospitalized at the Division of Eating and Nutrition Disorders (END), San Giuseppe Hospital, Istituto Auxologico Italiano, IRCCS, Piancavallo (VB), Italy Exclusion Criteria: * Absence of signed Informed Consent Control group: Inclusion Criteria: * Female sex * Age: 18 years or older * BMI between 18.5 and 24.9 kg/m2 Exclusion Criteria: * Absence of signed Informed Consent

Contact & Investigator

Central Contact

Alessandro Sartorio, MD

✉ sartorio@auxologico.it

📞 +390261911

Frequently Asked Questions

Who can join the NCT06800937 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying Anorexia Nervosa. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06800937 currently recruiting?

Yes, NCT06800937 is actively recruiting participants. Contact the research team at sartorio@auxologico.it for enrollment information.

Where is the NCT06800937 trial being conducted?

This trial is being conducted at Oggebbio, Italy.

Who is sponsoring the NCT06800937 clinical trial?

NCT06800937 is sponsored by Istituto Auxologico Italiano. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology